There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vera Therapeutics (VERA – Research Report), ...

Shares of Vera Therapeutics stock opened at $29.93 on Thursday. The stock has a market capitalization of $1.90 billion, a P/E ratio of -11.47 and a beta of 1.11. The company has a quick ratio of ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Vera Therapeutics Inc (Symbol: VERA) entered into oversold territory, hitting an RSI ...

Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for ...

Investing.com’s Fair Value model demonstrated remarkable accuracy in identifying overvalued stocks, as evidenced by its September 2024 analysis of Vera Therapeutics (NASDAQ:VERA). The model’s ...

Vera stock dropped after Otsuka announced plans for accelerated approval of sibeprenlimab, but analysts believe the selloff was an overreaction. Atacicept is more disease-modifying, while ...